Cargando…

EZH2 Phosphorylation Promotes Self-Renewal of Glioma Stem-Like Cells Through NF-κB Methylation

Cancer stem-like cells (CSCs) is a cell population in glioma with capacity of self-renewal and is critical in glioma tumorigenesis. Parallels between CSCs and normal stem cells suggest that CSCs give rise to tumors. Oncogenic roles of maternal embryonic leucine-zipper kinase (MELK) and enhancer of z...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hailong, Sun, Youliang, Qi, Xueling, Gordon, Renata E., O'Brien, Jenny A., Yuan, Hongyu, Zhang, Junping, Wang, Zeyuan, Zhang, Mingshan, Song, Yongmei, Yu, Chunjiang, Gu, Chunyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652807/ https://www.ncbi.nlm.nih.gov/pubmed/31380279 http://dx.doi.org/10.3389/fonc.2019.00641

Ejemplares similares

Neuraxis Metastases Of Primary Central Nervous System Tumors: A Review Of Clinicopathological And Radiographic Characters Of 198 Cases In A Single Center
por: Liu, Hailong, et al.
Publicado: (2019)

Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center
por: Liu, Hailong, et al.
Publicado: (2019)

Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential
por: Liu, Hailong, et al.
Publicado: (2017)

Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling
por: Lan, Tian, et al.
Publicado: (2016)

Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome
por: Aoyama, Kazumasa, et al.
Publicado: (2018)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

EZH2 is a potential prognostic predictor of glioma
por: Chen, Yi‐nan, et al.
Publicado: (2020)

Primary intracranial neuroendocrine tumor: two case reports
por: Liu, Hailong, et al.
Publicado: (2016)

Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE
por: Ye, Cuifang, et al.
Publicado: (2022)

MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma
por: Zhang, Yuan, et al.
Publicado: (2019)

Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
por: Qiao, Li, et al.
Publicado: (2019)

Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma
por: Zhang, Yaqin, et al.
Publicado: (2017)

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
por: Sun, Si, et al.
Publicado: (2020)

si-PDGFRβ-Loaded Exosomes Suppress the Progression of Glioma by Inhibiting the Oxidative Associated PI3K/Akt/EZH2 Signaling Pathway
por: Li, Yuping, et al.
Publicado: (2022)

SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation
por: Li, Xiaopeng, et al.
Publicado: (2017)

miR-22-5p regulates the self-renewal of spermatogonial stem cells by targeting EZH2
por: Lv, Wenqiang, et al.
Publicado: (2022)

Pineal region metastasis with intraventricular seeding: A case report and literature review
por: Ji, Junpeng, et al.
Publicado: (2019)

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
por: Dhar, Swati, et al.
Publicado: (2022)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma
por: Wang, Yingyi, et al.
Publicado: (2016)

Retraction: SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation
por: Li, Xiaopeng, et al.
Publicado: (2022)

Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner
por: Yu, Feng, et al.
Publicado: (2023)

Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition
por: Jin, Xun, et al.
Publicado: (2017)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
por: Wang, Xiang, et al.
Publicado: (2019)

A TNF-NF-κB-STAT3 loop triggers resistance of glioma-stem-like cells to Smac mimetics while sensitizing to EZH2 inhibitors
por: Tannous, Bakhos A., et al.
Publicado: (2019)

Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition
por: da Hora, Cintia Carla, et al.
Publicado: (2019)

EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner
por: Kim, Sung-Hak, et al.
Publicado: (2015)

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression
por: He, Xin, et al.
Publicado: (2023)

NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes
por: Minnebo, Nikki, et al.
Publicado: (2013)

Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells
por: Collinson, Adam, et al.
Publicado: (2016)

DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity
por: Wang, Y, et al.
Publicado: (2016)

Correction: Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner
por: Yu, Feng, et al.
Publicado: (2023)

Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells
por: Jin, Mengyuan, et al.
Publicado: (2021)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity
por: He, Shan, et al.
Publicado: (2017)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

ET-03 Convection-enhanced delivery of EZH2 inhibitor for the treatment of diffuse midline glioma
por: Sasaki, Takahiro, et al.
Publicado: (2020)

Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas
por: Keane, Lily, et al.
Publicado: (2021)

NF‐κB/NKILA signaling modulates the anti‐cancerous effects of EZH2 inhibition
por: Duan, Suzann, et al.
Publicado: (2019)

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
por: Han, Bo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dpi1fm3l581pof65q04dsahh5a